Source: https://www.rcptm.com/about/personnel/igor-popa/
Timestamp: 2019-04-21 13:23:00+00:00

Document:
HomeAboutPersonnel Mgr. Igor Popa, Ph.D.
Autor nebo spoluautor 7 patentů.
E. Schutznerová, I. Popa, V. Kryštof, H. Koshino, Zdeněk Trávníček, P. Hradil, P. Cankař: Utilization of DmbNHNH2 in the synthesis of amino-substituted 4-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenols, Tetrahedron 68 3996-4002 (2012).
M. Kubala, J. Vacek, I. Popa, M. Janovská, P, Kosina, J. Ulrichová, Z. Trávníček, V. Šimánek: The fluorescens properties and NMR analysis of protropine and allocryptopine, Journal of Luminiscence 131 1340-1345 (2011).
L. Dvořák, I. Popa, P. Štarha, Z. Trávníček: In Vitro Cytotoxic Active Platinum(II) Complexes Derived from Carboplatin and Involving Purine Derivatives, European Journal of Inorganic Chemistry 22 3441-3448 (2010).
E. Schuetznerova, I. Popa, V. Krystof, H. Koshino, Z. Travnicek, P. Hradil, and P. Cankar, “Utilization of DmbNHNH(2) in the synthesis of amino-substituted 4-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenols,” TETRAHEDRON, vol. 68, iss. 21, pp. 3996-4002, 2012.
M. Kubala, J. Vacek, I. Popa, M. Janovska, P. Kosina, J. Ulrichova, Z. Travnicek, and V. Simanek, “The fluorescence properties and NMR analysis of protopine and allocryptopine,” JOURNAL OF LUMINESCENCE, vol. 131, iss. 7, pp. 1340-1345, 2011.
Z. Travnicek, P. Starha, I. Popa, R. Vrzal, and Z. Dvorak, “Roscovitine-based CDK inhibitors acting as N-donor ligands in the platinum(II) oxalato complexes: Preparation, characterization and in vitro cytotoxicity,” EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 45, iss. 10, pp. 4609-4614, 2010.
A. Klanicova, Z. Travnicek, J. Vanco, I. Popa, and Z. Sindelar, “Dinuclear copper(II) perchlorate complexes with 6-(benzylamino)purine derivatives: Synthesis, X-ray structure, magnetism and antiradical activity,” POLYHEDRON, vol. 29, iss. 13, pp. 2582-2589, 2010.
L. Dvorak, I. Popa, P. Starha, and Z. Travnicek, “In Vitro Cytotoxic-Active Platinum(II) Complexes Derived from Carboplatin and Involving Purine Derivatives,” EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, iss. 22, pp. 3441-3448, 2010.
P. Starha, Z. Travnicek, and I. Popa, “Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 104, iss. 6, pp. 639-647, 2010.
J. Nisler, M. Zatloukal, I. Popa, K. Dolezal, M. Strnad, and L. Spichal, “Cytokinin receptor antagonists derived from 6-benzylaminopurine,” PHYTOCHEMISTRY, vol. 71, iss. 7, pp. 823-830, 2010.
P. Starha, I. Popa, and Z. Travnicek, “Palladium(II) oxalato complexes involving N6-(benzyl)-9-isopropyladenine-based N-donor carrier ligands: Synthesis, general properties, H-1, C-13 and N-15\H-1\ NMR characterization and in vitro cytotoxicity,” INORGANICA CHIMICA ACTA, vol. 363, iss. 7, pp. 1469-1478, 2010.
Z. Travnicek, I. Popa, M. Cajan, R. Zboril, V. Krystof, and J. Mikulik, “The first iron(III) complexes with cyclin-dependent kinase inhibitors: Magnetic, spectroscopic (IR, ES+ MS, NMR, Fe-57 Mossbauer), theoretical, and biological activity studies,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 104, iss. 4, pp. 405-417, 2010.
Z. Travnicek, R. Pastorek, P. Starha, I. Popa, and V. Slovak, “Nickel(II) N-Benzyl-N-methyldithiocarbamato Complexes as Precursors for the Preparation of Graphite Oxidation Accelerators,” ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE, vol. 636, iss. 8, pp. 1557-1564, 2010.
M. Siller, P. Anzenbacher, E. Anzenbacherova, K. Dolezal, I. Popa, and M. Strnad, “Interactions of olomoucine II with main drug-metabolizing enzymes of human liver microsomal fraction,” TOXICOLOGY LETTERS, vol. 189, p. S108, 2009.
P. Starha, Z. Travnicek, and I. Popa, “Synthesis, characterization and in vitro cytotoxicity of the first palladium(II) oxalato complexes involving adenine-based ligands,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 103, iss. 7, pp. 978-988, 2009.
L. Spichal, T. Werner, I. Popa, M. Riefler, T. Schmelling, and M. Strnad, “PI-55 is a purine-derived cytokinin antagonist that blocks cytokinin action via receptor inhibition,” FEBS JOURNAL, vol. 276, pp. 390-391, 2009.
M. Siller, P. Anzenbacher, E. Anzenbacherova, K. Dolezal, I. Popa, and M. Strnad, “Interactions of Olomoucine II with Human Liver Microsomal Cytochromes P450,” DRUG METABOLISM AND DISPOSITION, vol. 37, iss. 6, pp. 1198-1202, 2009.
L. Szucova, L. Spichal, K. Dolezal, M. Zatloukal, J. Greplova, P. Galuszka, V. Krystof, J. Voller, I. Popa, F. J. Massino, J. Jorgensen, and M. Strnad, “Synthesis, characterization and biological activity of ring-substituted 6-benzylamino-9-tetrahydropyran-2-yl and 9-tetrahydrofuran-2-ylpurine derivatives,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 17, iss. 5, pp. 1938-1947, 2009.
P. Starha, Z. Travnicek, R. Herchel, I. Popa, P. Suchy, and J. Vanco, “Dinuclear copper(II) complexes containing 6-(benzylamino)purines as bridging ligands: Synthesis, characterization, and in vitro and in vivo antioxidant activities,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 103, iss. 3, pp. 432-440, 2009.
L. Spichal, T. Werner, I. Popa, M. Riefler, T. Schmuelling, and M. Strnad, “The purine derivative PI-55 blocks cytokinin action via receptor inhibition,” FEBS JOURNAL, vol. 276, iss. 1, pp. 244-253, 2009.
Z. Travnicek, J. Mikulik, M. Cajan, R. Zboril, and I. Popa, “Novel iron complexes bearing N6-substituted adenosine derivatives: Synthesis, magnetic, (57)Fe Mossbauer, DFT, and in vitro cytotoxicity studies,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 16, iss. 18, pp. 8719-8728, 2008.
L. Szucova, Z. Travnicek, I. Popa, and J. Marek, “Preparation and cis-to-trans transformation study of square-planar [Pt(L(n))2Cl(2)] complexes bearing cytokinins derived from 6-benzylaminopurine (L(n)) by view of NMR spectroscopy and X-ray crystallography,” POLYHEDRON, vol. 27, iss. 12, pp. 2710-2720, 2008.
Z. Travnicek, I. Popa, M. Cajan, R. Herchel, and J. Marek, “The first platinum(IV) complexes involving aromatic cytokinins or cyclin-dependent kinase inhibitors derived from 6-benzylaminopurine: X-ray structures of (BohH(2)(2+))[PtCl6] center dot H2O and (RosH(2)(2+))(2)[PtCl6]Cl-2 center dot 4H(2)O,” POLYHEDRON, vol. 26, iss. 18, pp. 5271-5282, 2007.
K. Dolezal, I. Popa, E. Hauserova, L. Spichal, K. Chakrabarty, O. Novak, V. Krystof, J. Voller, J. Holub, and M. Strnad, “Preparation, biological activity and endogenous occurrence of N-6-benzyladenosines,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 15, iss. 11, pp. 3737-3747, 2007.
Z. Travnicek, L. Szucova, and I. Popa, “Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl-2] complexes involving 6-benzylamino-9-isopropylpurine derivatives,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 101, iss. 3, pp. 477-492, 2007.
Z. Travnicek and I. Popa, “2-chloro-6-[(4-hydroxy-3,5-dimethoxybenzyl)amino]-9-isopropylpurine,” ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, vol. 63, iss. Part 2, p. O728-O730, 2007.
Z. Travnicek and I. Popa, “2-chloro-6-[(2,6-dimethoxybenzyl)amino]9-isopropylpurine 0.125-hydrate,” ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, vol. 63, iss. Part 2, p. O629-O631, 2007.
J. Stranska, M. Sebela, P. Tarkowski, P. Rehulka, J. Chmelik, I. Popa, and P. Pec, “Inhibition of plant amine oxidases by a novel series of diamine derivatives,” BIOCHIMIE, vol. 89, iss. 1, pp. 135-144, 2007.
F. Sersen, D. Loos, J. Csollei, I. Popa, J. Vanco, and F. Gregan, “Antioxidative activity of potential antihypertensives with dual effect,” CHEMICKE LISTY, vol. 101, iss. 1, pp. 60-64, 2007.
A. Klanicova, Z. Travnicek, I. Popa, M. Cajan, and K. Dolezal, “Synthesis, characterization and in vitro cytotoxicity of Co(II) complexes with N6-substituted adenine derivatives: X-ray structures of 6-(4-chlorobenzylamino)purin-di-ium diperchlorate dihydrate and [Co-6(mu-L-6)(4)Cl-8(DMSO)(10)] center dot 4DMSO,” POLYHEDRON, vol. 25, iss. 6, pp. 1421-1432, 2006.
Z. Travnicek, J. Marek, and I. Popa, “6-(2-Chloro-4-fluorobenzylamino)purine,” ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, vol. 62, iss. Part 4, p. O1536-O1538, 2006.
K. Dolezal, I. Popa, V. Krystof, L. Spichal, M. Fojtikova, J. Holub, R. Lenobel, T. Schmulling, and M. Strnad, “Preparation and biological activity of 6-benzylaminopurine derivatives in plants and human cancer cells,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 14, iss. 3, pp. 875-884, 2006.
L. Szucova, Z. Travnicek, M. Zatloukal, and I. Popa, “Novel platinum(II) and palladium(II) complexes with cyclin-dependent kinase inhibitors: Synthesis, characterization and antitumour activity,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 14, iss. 2, pp. 479-491, 2006.
E. Hauserova, J. Swaczynova, K. Dolezal, R. Lenobel, I. Popa, M. Hajduch, D. Vydra, K. Fuksova, and M. Strnad, “Batch immunoextraction method for efficient purification of aromatic cytokinins,” JOURNAL OF CHROMATOGRAPHY A, vol. 1100, iss. 1, pp. 116-125, 2005.
Z. Travnicek, M. Sipl, and I. Popa, “Palladium(II) complexes containing cytokinins derived from 6-benzylaminopurine,” JOURNAL OF COORDINATION CHEMISTRY, vol. 58, iss. 16, pp. 1513-1521, 2005.
Z. Travnicek, A. Klanicova, I. Popa, and J. Rolcik, “Synthetic, spectral, magnetic and in vitro cytotoxic activity studies of cobalt(II) complexes with cytokinin derivatives: X-ray structure of 6-(3-methoxybenzylamino)purinium chloride monohydrate,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 99, iss. 3, pp. 776-786, 2005.
Z. Travnicek, I. Popa, and K. Dolezal, “6-(4-methoxybenzylamino)purin-3-ium chloride,” ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, vol. 60, iss. Part 9, p. O662-O664, 2004.
Z. Travnicek, M. Malon, I. Popa, K. Dolezal, and M. Strnad, “Preparation and cytotoxic activity of nickel(II) complexes with 6-benzylaminopurine derivatives,” TRANSITION METAL CHEMISTRY, vol. 27, iss. 8, pp. 918-923, 2002.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.